|
Patents
(US, UK) for a novel electronic spirometer are available for licensing
or assignment. Spirometers are devices for measuring lung performance
to diagnose and monitor patients with respiratory diseases. The main
diseases are asthma (300 million patients worldwide) and chronic obstructive
pulmonary disease (COPD) which has an estimated 50 million patients in
the US, Europe and Japan. All of these persons would benefit from
regulatory monitoring of their condition with spirometers. The market
for spirometers is estimated at $2 billion in 2010 for the US, Europe
and Japan alone. The technology described in the patent is for a
spirometer that has high speed air flow measurement ability with a MEMs
pressure sensor, a simple design with no moving parts, and a fully
electronic design. This spirometer design has key advantages over
existing spirometers that include high accuracy and potential for low
cost production.
|